Chikuma Hamada
Faculty of Engineering
Tokyo University of Science
Kagurazaka Shinjuku-ku
Tokyo 162-8601
Japan
Name/email consistency: high
- Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit? Hamada, C., Sakamoto, J., Satoh, T., Sadahiro, S., Mishima, H., Sugihara, K., Saji, S., Tomita, N. Jpn. J. Clin. Oncol. (2011)
- Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials. Hamada, C., Tsuboi, M., Ohta, M., Fujimura, S., Kodama, K., Imaizumi, M., Wada, H. J. Thorac. Oncol (2009)
- The role of meta-analysis in cancer clinical trials. Hamada, C. Int. J. Clin. Oncol. (2009)
- Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. Hamada, C., Tanaka, F., Ohta, M., Fujimura, S., Kodama, K., Imaizumi, M., Wada, H. J. Clin. Oncol. (2005)
- Projection of creutzfeldt-jakob disease frequency based on cadaveric dura transplantation in Japan. Hamada, C., Sadaike, T., Fukushima, M. Neuroepidemiology (2003)









